YTHDF1 and non-small cell lung carcinoma: Recent work reported that the deficiency of YTHDF1 inhibited translational efficiency of Keap1 and activated the antioxidant reactive oxygen species (ROS) clearance system (Nrf2-AKR1C1) under DDP therapeutic burden, which leads to a bad prognosis of NSCLC patients (72).